Lawsuits allege Risperdal (risperidone) caused gynecomastia — abnormal breast tissue growth — in boys and young men, and that the manufacturer failed to adequately warn of the hormonal side effect.
Risperdal (risperidone) is an antipsychotic prescribed for schizophrenia, bipolar disorder, and irritability associated with autism — frequently to children and adolescents. The drug can elevate prolactin, a hormone linked to breast tissue growth.
Lawsuits allege the manufacturer knew of elevated gynecomastia risk in young males — particularly at pediatric doses — and failed to adequately warn patients and prescribers. Internal documents and past jury findings have supported claims that risk information was minimized.
Thousands of claims have been filed over the past decade — many resolved through settlements — and new claims continue to be evaluated, particularly for individuals who took the drug as children or teens and later developed gynecomastia.
Risperdal litigation has produced substantial settlements and verdicts over the past decade, and thousands of claims have resolved. New claims continue to be evaluated — particularly for those who took the drug as minors.
Qualification criteria change as litigation develops. The only way to know whether your experience may fit the current criteria is a review.
The Risperdal campaign is pre-selected below. Tell us what happened — a specialist will review whether your information may fit the current criteria.
You are reviewing: Risperdal Claims. Complete the form — a case specialist may follow up if your information appears to fit.
Attorney advertising. The Torts Attorney provides legal marketing and case-acquisition services and is not a law firm. Submitting this form does not create an attorney-client relationship and does not guarantee review, acceptance, or any outcome. Prior results do not guarantee similar outcomes.